LS ARK Genomic Revolution Tracker ETP Securities XS2399368062
2.68
EUR
-0.08
EUR
-2.77 %
18:22:36
NAV
| Kurse | Charts | Stammdaten | Kennzahlen | Aktion |
|---|---|---|---|---|
| Snapshot | Preischart | Daten + Gebühr | Performance | Portfolio |
| Börsenplätze | Performance | Management | Volatilität | Watchlist |
| Historisch | Benchmark | Sharpe Ratio | ||
| Rendite | Ratings |
Kurse
Charts
Stammdaten
Kennzahlen
Nettoinventarwert (NAV)
| 3.16 USD | -0.06 USD | -1.79 % |
|---|
| Vortag | 3.22 USD | Datum | 22.07.2026 |
LS ARK Genomic Revolution Tracker ETP Securities Kurs - 1 Jahr
Anzeige
Top Kryptowährungen ETPs
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Injective Staking ETP | CH1360612134 | 49.98% | |
| 21Shares Ondo ETP | CH1396389921 | 46.90% | |
| 21shares Hyperliquid Staking ETP | CH1471826029 | 42.17% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 27.74% | |
| 21Shares Uniswap ETP | CH1135202096 | 16.00% | |
| 21Shares Pendle ETP | CH1495416997 | 14.25% | |
| 21shares Gram Staking ETP | CH1297762812 | 11.18% | |
| 21Shares Jupiter ETP | CH1480821383 | 5.19% | |
| 21shares Strategy Yield ETP USD | CH1528107811 | -10.18% | |
| 21Shares XDC Network ETP | CH1464217285 | -10.38% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21shares Hyperliquid Staking ETP | CH1471826029 | 158.85% | |
| 21shares Morpho ETP | CH1506167027 | 61.15% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | 19.26% | |
| 21Shares Injective Staking ETP | CH1360612134 | 10.78% | |
| 21Shares Ondo ETP | CH1396389921 | 8.06% | |
| 21shares Gram Staking ETP | CH1297762812 | -3.96% | |
| 21Shares Jupiter ETP | CH1480821383 | -6.71% | |
| 21Shares Bittensor ETP | CH1495416971 | -22.99% | |
| 21Shares Pendle ETP | CH1495416997 | -27.96% | |
| 21Shares XDC Network ETP | CH1464217285 | -33.46% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares Bitcoin Gold ETP | CH1146882308 | -3.61% | |
| 21Shares Binance BNB ETP | CH0496454155 | -28.53% | |
| 21Shares NEAR Protocol Staking ETP | CH1162108893 | -32.46% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -44.52% | |
| 21Shares Bitcoin ETP | CH0454664001 | -45.27% | |
| 21Shares Cronos Staking ETP | CH1443364232 | -55.52% | |
| 21Shares Injective Staking ETP | CH1360612134 | -61.94% | |
| 21Shares XDC Network ETP | CH1464217285 | -68.74% | |
| 21Shares Dogecoin ETP | CH1431521033 | -70.00% | |
| 21Shares Sui Staking ETP | CH1360612159 | -80.61% |
| Name | ISIN | Performance | |
|---|---|---|---|
| 21Shares XRP ETP | CH0454664043 | 67.63% | |
| 21Shares Stellar ETP | CH1109575535 | 65.38% | |
| 21Shares Bitcoin Gold ETP | CH1146882308 | 48.44% | |
| 21Shares Crypto Basket Equal Weight (HODLV) ETP | CH1135202161 | 9.43% | |
| 21Shares Bitcoin Core ETP | CH1199067674 | -1.79% | |
| 21Shares Sui Staking ETP | CH1360612159 | -6.01% | |
| 21Shares Injective Staking ETP | CH1360612134 | -79.83% |
Fundamentaldaten
| Valor | |
| ISIN | XS2399368062 |
| Emittent | Leverage Shares PLC |
| Aufgelegt in | Ireland |
| Auflagedatum | 10.12.2021 |
| Kategorie | Branchen: Biotechnologie |
| Währung | USD |
| Volumen | 911’116.72 |
| Depotbank | |
| Geschäftsjahresende | |
| Berichtsstand | 24.07.2026 |
Anlagepolitik
So investiert der LS ARK Genomic Revolution Tracker ETP Securities: The objective of the ETP is to track the ARKG Genomic Tracker Investment Strategy, (the 'Investment Strategy') which is designed to provide 1:1 exposure to the performance of ARK Genomic Revolution ETF (the “Reference Asset”), minus a fee. It invests all subscription proceeds and dividends received (net of taxes) directy into Reference Assets.
ETP Performance: LS ARK Genomic Revolution Tracker ETP Securities
| Performance 1 Jahr | 45.71 | |
| Performance 2 Jahre | 43.85 | |
| Performance 3 Jahre | 3.43 | |
| Performance 5 Jahre | - | |
| Performance 10 Jahre | - |